Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/196781
Type: Artigo de periódico
Title: Morphological And Growth Alterations In Vero Cells Transformed By Cisplatin.
Author: Gonçalves, Estela Maria
Ventura, Cláudio Angelo
Yano, Tomomasa
Rodrigues Macedo, Maria Lígia
Genari, Selma Candelária
Abstract: Cisplatin is an antineoplastic agent used to treat solid tumours, such as ovarian, testicular and bladder tumours. However, studies in vitro and in vivo have shown that cisplatin is mutagenic, genotoxic and tumorigenic in other tissues and organs. In this work, we examined the effect of cisplatin on Vero cells, a fibroblast-like cell line. The morphological characteristics were investigated using phase contrast microscopy, scanning electron microscopy and the actin cytoskeleton was labelled with fluorescein isothiocyanate-phalloidin. Cell proliferation was assessed based on the growth curve. Cultured Vero cells treated with cisplatin showed behavioural and morphological alterations associated with cellular transformation. The transformed cells grew in multilayers and formed cellular aggregates. The proliferation and morphological characteristics of the transformed cells were very different from those of control ones. Since transformed Vero cells showed several characteristics related to neoplastic growth, these cells could be a useful model for studying tumour cells in vitro.
Subject: Actins
Animals
Antineoplastic Agents
Carcinogenicity Tests
Cell Culture Techniques
Cell Division
Cell Line
Cell Shape
Cell Transformation, Neoplastic
Cercopithecus Aethiops
Cisplatin
Microscopy, Electron, Scanning
Microscopy, Phase-contrast
Vero Cells
Rights: fechado
Identifier DOI: 10.1016/j.cellbi.2005.12.007
Address: http://www.ncbi.nlm.nih.gov/pubmed/16716608
Date Issue: 2006
Appears in Collections:Artigos e Materiais de Revistas Científicas - Unicamp

Files in This Item:
File SizeFormat 
pmed_16716608.pdf844.67 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.